OPM-101

· Oncodesign Precision Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OPM-101, covering 2025-06-27 to 2025-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1 [Phase 1, Phase 2]

See pricing